2.985
price down icon2.45%   -0.075
after-market Dopo l'orario di chiusura: 3.02 0.035 +1.17%
loading
Precedente Chiudi:
$3.06
Aprire:
$3.21
Volume 24 ore:
2.29M
Relative Volume:
1.01
Capitalizzazione di mercato:
$674.86M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
83.61
EPS:
0.0357
Flusso di cassa netto:
$6.55M
1 W Prestazione:
-43.89%
1M Prestazione:
-29.93%
6M Prestazione:
-13.48%
1 anno Prestazione:
-1.49%
Intervallo 1D:
Value
$2.98
$3.32
Intervallo di 1 settimana:
Value
$2.90
$5.55
Portata 52W:
Value
$2.28
$6.71

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name
Nome
Organogenesis Holdings Inc
Name
Telefono
781-575-0775
Name
Indirizzo
85 DAN ROAD, CANTON, MA
Name
Dipendente
869
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ORGO's Discussions on Twitter

Confronta ORGO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ORGO
Organogenesis Holdings Inc
2.985 674.86M 433.14M 4.95M 6.55M 0.0357
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
161.92 70.37B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.19 48.41B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.71 47.91B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.96 18.80B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
310.80 13.47B 2.76B 1.11B 898.10M 22.77

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-28 Iniziato Lake Street Buy
2024-02-07 Iniziato Cantor Fitzgerald Overweight
2023-06-15 Iniziato Morgan Stanley Equal-Weight
2023-05-24 Aggiornamento BTIG Research Neutral → Buy
2022-11-10 Downgrade BTIG Research Buy → Neutral
2022-08-10 Downgrade Oppenheimer Outperform → Perform
2020-01-10 Iniziato SVB Leerink Outperform
2019-08-26 Ripresa Credit Suisse Outperform
2019-05-02 Iniziato Credit Suisse Outperform
2019-04-17 Iniziato Oppenheimer Outperform
2019-04-11 Iniziato SunTrust Buy
Mostra tutto

Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie

pulisher
May 11, 2025

Dimensional Fund Advisors LP Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

May 11, 2025
pulisher
May 11, 2025

Barclays PLC Grows Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

May 11, 2025
pulisher
May 11, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Wells Fargo & Company MN - Defense World

May 11, 2025
pulisher
May 10, 2025

Organogenesis Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Organogenesis (NASDAQ:ORGO) Shares Gap Down After Earnings Miss - Defense World

May 10, 2025
pulisher
May 09, 2025

Organogenesis Faces Challenges but Sees Growth Potential - TipRanks

May 09, 2025
pulisher
May 09, 2025

Organogenesis: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

38,341 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Mariner LLC - Defense World

May 09, 2025
pulisher
May 09, 2025

Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Call Highlights: Navigating Market ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummets - Investing.com

May 09, 2025
pulisher
May 09, 2025

Organogenesis Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

ORGO Reveals FY25 Adjusted EBITDA Outlook and ReNu Development Progress | ORGO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Organogenesis Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Daily Market Movement: Organogenesis Holdings Inc (ORGO) Sees a -2.26 Decrease, Closing at 5.20 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Organogenesis (ORGO) Expected to Announce Earnings on Thursday - Defense World

May 07, 2025
pulisher
May 06, 2025

Organogenesis Holdings Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 04, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Catapults 36% Though Its Price And Business Still Lag The Industry - simplywall.st

May 04, 2025
pulisher
May 02, 2025

ORGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

How does Organogenesis Holdings Inc (ORGO) change from a tortoise to a hare? - Sete News

May 02, 2025
pulisher
May 02, 2025

Wound Care Biologics Market to Witness Massive Growth by 2032 | - openPR.com

May 02, 2025
pulisher
May 02, 2025

Organogenesis Holdings Inc (NASDAQ: ORGO) Could Slash -20.97% Soon - Stocksregister

May 02, 2025
pulisher
May 01, 2025

Organogenesis Holdings Inc (ORGO) stock on the rise: An overview - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Recent Insider Activity Could Benefit Organogenesis Holdings Inc (ORGO) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

Financial Metrics Unveiled: Organogenesis Holdings Inc (ORGO)’s Key Ratios in the Spotlight - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Raised by JPMorgan Chase & Co. - Defense World

Apr 29, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Sells 7,694 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

Market cap of Organogenesis Holdings Inc [ORGO] reaches 574.53M – now what? - dbtnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Riding the Waves: A Guide to Investing in ORGO Stock - investchronicle.com

Apr 25, 2025
pulisher
Apr 24, 2025

Organogenesis Holdings Inc (ORGO) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Organogenesis Holdings Inc (ORGO) Stock Behavior Isn’t As Predictable As You Think - Stocksregister

Apr 24, 2025
pulisher
Apr 23, 2025

Daily Market Movement: Organogenesis Holdings Inc (ORGO) Sees a 2.85 Increase, Closing at 4.33 - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

A Detailed Analysis Of Organogenesis Holdings Inc (ORGO) - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

Lake Street’s latest rating for ORGO stock - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

Alliancebernstein L.P. Has $585,000 Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Amniotic Membrane Market Set to Witness Significant Growth - openPR.com

Apr 18, 2025
pulisher
Apr 15, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by American Century Companies Inc. - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - The Manila Times

Apr 12, 2025
pulisher
Apr 11, 2025

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Medicare Coverage Shift for Wound Care Products Paused: What This Means for Patient Access - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

Sei Investments Co. Cuts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

High Growth Tech Stocks In The US To Watch April 2025 - simplywall.st

Apr 08, 2025
pulisher
Apr 08, 2025

Prudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - The Manila Times

Apr 08, 2025
pulisher
Apr 07, 2025

Organogenesis Sets Key Q1 Earnings Date: What Investors Should Watch - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

Insider-Favored Growth Companies Including Organogenesis Holdings And Two More - simplywall.st

Apr 04, 2025

Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Organogenesis Holdings Inc Azioni (ORGO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Driscoll Michael Joseph
Director
Mar 04 '25
Sale
5.10
25,000
127,535
166,879
Gillheeney Gary S.
President and CEO
Dec 13 '24
Sale
3.36
55,615
186,866
3,044,779
Gillheeney Gary S.
President and CEO
Dec 16 '24
Sale
3.49
5,585
19,492
3,039,194
Gillheeney Gary S.
President and CEO
Dec 11 '24
Sale
3.64
157,448
573,111
3,143,753
Gillheeney Gary S.
President and CEO
Dec 10 '24
Sale
3.64
58,525
213,031
3,301,201
Gillheeney Gary S.
President and CEO
Dec 12 '24
Sale
3.55
43,359
153,924
3,100,394
Gillheeney Gary S.
President and CEO
Dec 05 '24
Option Exercise
0.99
1,067,245
1,056,573
3,419,194
Gillheeney Gary S.
President and CEO
Dec 09 '24
Sale
3.52
41,052
144,503
3,359,726
Gillheeney Gary S.
President and CEO
Dec 06 '24
Sale
3.65
18,416
67,218
3,400,778
$31.27
price up icon 3.78%
$79.52
price down icon 2.72%
$8.96
price up icon 2.17%
$120.43
price up icon 4.08%
drug_manufacturers_specialty_generic RDY
$13.93
price up icon 3.96%
$310.80
price up icon 3.11%
Capitalizzazione:     |  Volume (24 ore):